Sino-Biocan cell preparation tools production base inaugurated in Shanghai

The opening celebration of Sino-Biocan Shanghai production base was held on 18^th November 2021, in Shanghai Lingang Nanqiao Science and Technology City.

Sino-Biocan (Shanghai) Biotech Ltd is an automated, modularized, closed cell production platform provider in cell & gene therapy field, providing total solution of smart tools innovation and service, devoting to be the industry leader integrating R&D, business development, techinical service, customization and production.

Sino-Biocan has developed a GMP-grade product family of fully closed, modularized, continuous cell preparation tools, as well as consumables and liquid solution, covering processes such as automated cell separation, culture, cell concentration, washing and formulation filling, cryopreservation and recovery, widely applied in cell and gene drug development, CDMO, medical and pharmaceutical stem cell preparation and application, cord blood bank management and cell storage, etc. We can also provide modular splicing of different GMP processes according to specific customer requirements for different pipelines, to realize the rapid, efficient and differentiated customization of series products of cell preparation tools.

The production base with a total area of 7600㎡in Shanghai Lingang Nanqiao Science and Technology City, which includes GMP-grade C+A consumable clean workshop, pharmaceutical grade liquid clean workshop, NMPA medical device production workshop, C+A cell & gene therapy process research and validation lab, equipment R&D lab, high clean level fully functional QC center, high level low-temperature and room-temperature warehouse, reaching production scale of 200,000 sets of consumables, 600,000 bottles of liquid reagents and 3,000 sets of equipment per year for cell & gene therapy preparation.

During the opening ceremony, many well-known medical companies signed contracts with Sino-Biocan. The participation of many partners not only accelerates the development and growth of cell therapy industry, but also greatly enhances the confidence for Sino-Biocan to produce high quality and cost-effectively cell and gene related products.